GlassScriptPhysician profile
Andi Peshkepija
NPI 1912347279
$24,149.45
in general payments reported to CMS, 2019-2025
10 companies · $2,926 in 2025
The $2,926 reported for 2025 was more than what 77% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,598 · 2020: $53.38 · 2021: $546 · 2022: $5,812 · 2023: $4,779 · 2024: $6,436 · 2025: $2,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,212 · Travel and Lodging: $5,479 · Consulting Fee: $2,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,211.55 |
| Travel and Lodging | $5,479.36 |
| Consulting Fee | $2,450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $6,801.08 | 2021-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $5,873.55 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Medical LLC | $4,783.01 | 2019-2025 | Zenith Alpha, Zenith Spiral-Z, Zenith |
| Silk Road Medical, INC. | $2,974.67 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Incorporated | $1,613.67 | 2023-2025 | Zenith Alpha |
| Medtronic Vascular, INC. | $870.57 | 2019 | |
| Endologix LLC | $577.88 | 2019-2025 | Alto Abdominal Stent Graft System |
| Philips North America LLC | $317.05 | 2019-2025 | Fors Equipment, Azurion 7 M20 |
| Medtronic, INC. | $226.31 | 2022-2025 | Valiant Captivia, Endurant Iis |
| Penumbra, INC. | $111.66 | 2024-2025 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andi Peshkepija listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.